Aligos Therapeutics, Inc.

ALGS·NasdaqCM
Compare
5.53+0.19 (+3.56%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close5.34
Open5.50
Day range5.335.57
52-week range3.9813.69
Off day high−0.72%
Off 52-week high−59.60%
Volume57.27K
Avg. volume (3M)85.35K
Market cap34.53M
EPS (TTM)-7.41
Forward P/E-1.05
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding5.44M
Short interest—
Earnings dateAug 6, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
ALGS TOVX TVGN MREO CHRS ALDX
Market cap 34.53M 10.07M 43.49M 50.33M 159.14M 54.64M
P/E (TTM) — 0.3 — — — —
Forward P/E -1.1 -1.1 — -13.8 -1.6 -3.3
Price/book 1.1 0.8 -1.5 1.8 2.6 1.4
Dividend yield — — — — — —
1-year change −42.75% −51.11% −81.03% −82.50% −38.15% −83.03%
Today +3.56% +1.11% −1.50% −9.92% −3.74% −1.15%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ALGS news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.